Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Hip BMD and estimated glomerular filtration rate (eGFR) were lower in women than in men, while hypertension was similar between the sexes (Table 1 and 2).Clinical characteristics of the whole population, according to sex: continuous variablesWomenN = 107MenN = 259Whole populationN = 366P valueNMean ± SDNMean ± SDNMean ± SDAge (years)10750.7 ± 11.625953.4 ± 9.936652.6 ± 10.50.065Weight (kg)10366.7 ± 13.625878.0 ± 14.436174.7 ± 15.0 < 0.001BMI (kg/m2)9625.5 ± 4.524625.5 ± 3.734225.5 ± 4.00.347MELD score10615.6 ± 9.725916.3 ± 8.536516.1 ± 8.90.487Laboratory GOT (U/L)9994 ± 16324679 ± 6034583 ± 1010.297 GPT (U/L)10072 ± 21124664 ± 11634666 ± 1500.010 Total bilirubin (mg/dL)1005.6 ± 7.12486.4 ± 14.13486.2 ± 12.50.590 GGT (U/L)9961.3 ± 57.424586.2 ± 91.434479.0 ± 83.80.004 ALP (U/L)98239 ± 169246219 ± 154344225 ± 1580.310 Urea nitrogen (mg/dL)9626.6 ± 18.024336.3 ± 33.133933.5 ± 29.90.020 Glucose (mg/dL)9590 ± 33245106 ± 40340101 ± 39 < 0.001 Albumin (g/dL)983.49 ± 0.622423.51 ± 0.673403.50 ± 0.660.708 INR991.77 ± 1.062461.56 ± 0.433451.62 ± 0.670.326 Platelet count (10^9/L)100117.5 ± 120.424892.0 ± 75.434899.3 ± 91.20.430 White blood cell (10^9/L)995.07 ± 3.602465.18 ± 3.313455.15 ± 3.390.261 Hemoglobin (g/dL)10010.89 ± 1.7624611.62 ± 2.1334611.41 ± 2.050.004Bone metabolism Lumbar BMD (g/cm2)130.83 ± 0.15270.89 ± 0.12400.87 ± 0.130.305 Lumbar T-score13−2.15 ± 1.2527−1.86 ± 1.0840−1.95 ± 1.130.479 Lumbar Z-score12−1.23 ± 1.2127−1.43 ± 1.0839−1.37 ± 1.110.761 Femur Neck BMD (g/cm2)120.67 ± 0.12280.75 ± 0.13400.72 ± 0.130.087 Femur Neck T-score12−1.71 ± 1.0528−1.37 ± 0.9140−1.47 ± 0.960.301 Femur Neck Z-score12−0.86 ± 0.8928−0.55 ± 0.9540−0.65 ± 0.930.400 Total Hip BMD (g/cm2)110.81 ± 0.17290.93 ± 0.16400.90 ± 0.170.058 Total Hip T-score11−1.39 ± 1.1729−0.72 ± 1.0140−0.91 ± 1.080.033 Total Hip Z-score11−0.75 ± 1.1429−0.36 ± 1.0140−0.47 ± 1.050.154 PTH (pg/mL)849 ± 431961 ± 862757 ± 750.559 Calcium (mg/dl)988.89 ± 0.662418.82 ± 0.623398.84 ± 0.630.513 Phosphate (mg/dL)823.10 ± 0.761993.12 ± 0.712813.11 ± 0.720.965 Magnesium (mg/dl)761.95 ± 0.301891.95 ± 0.302651.95 ± 0.300.920 Urinary Calcium (mg/24 h)99.02 ± 10.53236.91 ± 6.69327.51 ± 7.830.950Urinary Phosphate (g/24 h)91.08 ± 1.58190.64 ± 0.27280.78 ± 0.910.806 25OH Vitamin D (ng/mL)613 ± 83015 ± 73614 ± 70.445 Bone specific alkaline phosphatase (BSAP) (microg/L)244.8 ± 27.5729.8 ± 9.9933.1 ± 14.60.380 eGFR (mL/min)9980.27 ± 25.0324486.41 ± 28.5734384.64 ± 27.700.010 Serum creatinine (mg/dL)980.91 ± 0.732441.11 ± 0.843421.06 ± 0.82 < 0.001Clinical characteristics of the whole population, according to sex: categorical variablesWomenMenOverall populationP valueN = 107N = 259N = 366Fragility fractures40/107115/259155/3660.216Ethnicity White Caucasian1032543570.799 Other145 Total104258362Arterial hypertension18/10055/24573/3450.359Child: Pugh Missing1827450.064 A185573 B3870108 C33107140 Total107259366Alcohol17/107a101/259b118/366 < 0.001Smoking11/107a69/259b80/3660.001Vitamin D3 supplements1/10713/25914/3660.064PPI9/107a54/259b63/3660.004Calcium carbonate supplements1/1076/2597/3660.380Diabetes12/107a76/259b88/366 < 0.001Corticosteroid use14/107a16/259b30/3660.028Ascites59/107142/259201/3660.956Encephalopathy42/10797/259139/3660.747Hepatocellular carcinoma31/107a118/259b149/3660.003GI Hemorrhage10/10728/25938/3660.676Portal vein thrombosis12/10729/25941/3660.996Cirrhosis etiology Autoimmune hepatitis10a2b12 < 0.001 Cholestatic disease11a11b22 Viral39105144 MASH022 Alcoholic6a36b42 Cryptogenic/rare disease21a29b50 Multifactorial20a74b94 Total107259366Vertebral fractures36/107109/259145/3660.133Genant’s vertebral fracture grade Mild2466900.031 Moderate6a37b43 Severe6a6b12 Total36109145DXA WHO classification Normal BMD2570.838 Low BMD/osteopenia81220 Osteoporosis51015 Total152742Number. total numbersSubscript a and b within the same variable express P < 0.05
Source: Characteristics of liver transplant recipients: whole population and gender comparison. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
All patients were evaluated and managed at our center and received a standardized clinical, laboratory and radiological evaluation, including thoracic and abdominal imaging before LT aligned with local and national guidelines.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
High bone fracture risk in a large modern cohort of liver transplant recipients
Study design awaiting verification · Internal and Emergency Medicine · 2024
Original publication title
High bone fracture risk in a large modern cohort of liver transplant recipients
© The Author(s) 2024
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Liver transplantation (LT) has historically been associated with a high prevalence of osteoporosis, but most of the available data date back to late 1990s: early 2000s with limited sample size. Our aim was to assess the prevalence of bone fragility fractures and contributing factors in a large modern cohort of liver transplant recipients. Retrospective study of 429 consecutive patients receiving liver transplantation from 1/1/2010 to 31/12/2015. Final cohort included 366 patients. Electronic radiological images (lateral views of spine X-rays or Scout CT abdominal scans) performed within 6 months from LT, were blinded reviewed to screen for morphometric vertebral fractures.
Symptomatic clinical fragility fractures were recorded from the medical records. Patients with fragility fractures in the cohort were 155/366 (42.3%), with no significant differences between sexes. Most sustained vertebral fractures (145/155, 93.5%), mild or moderate wedges, with severe fractures more frequently observed in women. Multiple vertebral fractures were common (41.3%). Fracture rates were similar across different etiologies of cirrhosis and independent of diabetes or glucocorticoids exposure. Kidney function was significantly worse in women with fractures. Independently of age, sex, alcohol use, eGFR, and etiology of liver disease, low BMI was significantly associated with an increased risk for fractures (adjusted OR 1.058, 95%CI 1.001 to 1.118, P = 0.046).
Our study shows a considerable fracture burden in a large and modern cohort of liver transplant recipients. Given the very high prevalence of bone fractures, a metabolic bone disease screening should be implemented in patients awaiting liver transplantation.
Supplementary Information
The online version contains supplementary material available at 10.1007/s11739-024-03767-5.
Authors’ abstract
Liver transplantation (LT) has historically been associated with a high prevalence of osteoporosis, but most of the available data date back to late 1990s: early 2000s with limited sample size. Our aim was to assess the prevalence of bone fragility fractures and contributing factors in a large modern cohort of liver transplant recipients. Retrospective study of 429 consecutive patients receiving liver transplantation from 1/1/2010 to 31/12/2015. Final cohort included 366 patients. Electronic radiological images (lateral views of spine X-rays or Scout CT abdominal scans) performed within 6 months from LT, were blinded reviewed to screen for morphometric vertebral fractures.
Symptomatic clinical fragility fractures were recorded from the medical records. Patients with fragility fractures in the cohort were 155/366 (42.3%), with no significant differences between sexes. Most sustained vertebral fractures (145/155, 93.5%), mild or moderate wedges, with severe fractures more frequently observed in women. Multiple vertebral fractures were common (41.3%). Fracture rates were similar across different etiologies of cirrhosis and independent of diabetes or glucocorticoids exposure. Kidney function was significantly worse in women with fractures. Independently of age, sex, alcohol use, eGFR, and etiology of liver disease, low BMI was significantly associated with an increased risk for fractures (adjusted OR 1.058, 95%CI 1.001 to 1.118, P = 0.046).
Our study shows a considerable fracture burden in a large and modern cohort of liver transplant recipients. Given the very high prevalence of bone fractures, a metabolic bone disease screening should be implemented in patients awaiting liver transplantation.
Supplementary Information
The online version contains supplementary material available at 10.1007/s11739-024-03767-5.
Publication and source details
Original title: High bone fracture risk in a large modern cohort of liver transplant recipients
Guido Zavatta; Giovanni Vitale; Maria Cristina Morelli; Paolo Pianta; Laura Turco; Federica Mirici Cappa; Matteo Ravaioli; Matteo Cescon; Fabio Piscaglia; Paola Altieri; Uberto Pagotto; BOLTBO study group ; Francesca Caputo; Luca Vizioli; Sonia Berardi; Vittoria Vero; Anna Baldan; Roberto Di Donato; Letizia Anna Marcantoni; Mariachiara Corrado
Internal and Emergency Medicine · 2024
© The Author(s) 20242024https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.http://dx.doi.org/10.13039/501100003196Ministero della SaluteRC-2024-2789954Pagotto UbertoRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T09:19:24.595888+00:00
DOI: 10.1007/s11739-024-03767-5 · PMC11794375